HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$0.51
Day range
$0.49 - $0.54
Year range
$0.35 - $1.20
Market cap
41.06M USD
Avg Volume
566.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 986.00K | -63.79% |
Operating expense | 6.67M | -21.63% |
Net income | -34.86M | -51.88% |
Net profit margin | -3.54K | -319.43% |
Earnings per share | -0.22 | 58.49% |
EBITDA | -21.76M | 7.25% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 112.74M | 8.91% |
Total assets | 127.90M | 5.06% |
Total liabilities | 68.11M | 84.13% |
Total equity | 59.80M | — |
Shares outstanding | 78.11M | — |
Price to book | 0.65 | — |
Return on assets | -39.45% | — |
Return on capital | -63.53% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -34.86M | -51.88% |
Cash from operations | -22.75M | -1.60% |
Cash from investing | -88.64M | -543.37% |
Cash from financing | -19.00K | -1,800.00% |
Net change in cash | -111.41M | -4,551.65% |
Free cash flow | -15.53M | -13.38% |
About
Founded
2018
Headquarters
Website
Employees
67